Cargando…
Hypoxia-mimetic agents inhibit proliferation and alter the morphology of human umbilical cord-derived mesenchymal stem cells
BACKGROUND: The therapeutic efficacy of human mesenchymal stem cells (hMSCs) for the treatment of hypoxic-ischemic diseases is closely related to level of hypoxia in the damaged tissues. To elucidate the potential therapeutic applications and limitations of hMSCs derived from human umbilical cords,...
Autores principales: | Zeng, Hui-Lan, Zhong, Qi, Qin, Yong-Liang, Bu, Qian-Qian, Han, Xin-Ai, Jia, Hai-Tao, Liu, Hong-Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3166919/ https://www.ncbi.nlm.nih.gov/pubmed/21827650 http://dx.doi.org/10.1186/1471-2121-12-32 |
Ejemplares similares
-
Hypoxia Mimetic Agents for Ischemic Stroke
por: Davis, Charles K., et al.
Publicado: (2019) -
Effects of Hypoxia and Chitosan on Equine Umbilical Cord-Derived Mesenchymal Stem Cells
por: Griffon, D. J., et al.
Publicado: (2016) -
The Role of CDR1as in Proliferation and Differentiation of Human Umbilical Cord-Derived Mesenchymal Stem Cells
por: Yang, Lunyu, et al.
Publicado: (2019) -
Insight in Hypoxia-Mimetic Agents as Potential Tools for Mesenchymal Stem Cell Priming in Regenerative Medicine
por: Nowak-Stępniowska, Agata, et al.
Publicado: (2022) -
Comprehensive proteomic analysis of exosome mimetic vesicles and exosomes derived from human umbilical cord mesenchymal stem cells
por: Zhang, Zhaoxia, et al.
Publicado: (2022)